Navigation Links
Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709

High Concentrations Reached in Key Lung Compartments

REINACH and BASEL, Switzerland, March 29, 2007 /PRNewswire-FirstCall/ -- Arpida Ltd. today announced promising results of "first-in-man" studies with AR-709. These radiolabelled Human Microdose studies included a total of 19 healthy male volunteers.

This groundbreaking study is the first ever using Microdosing for the determination of drug concentrations in lung compartments. The results showed that AR-709 achieves high concentrations in bronchial mucosa (BM), epithelial lining fluid (ELF) and alveolar macrophages (AM), the three key compartments of the lungs where pathogens can reside and replicate. Moreover, the results of the studies show that AR-709 exhibited a large volume of distribution and a long half life in man. Oral bioavailability was potentially low but this could be due to the low dose, poor absorption or extensive metabolism.

The studies were conducted at Hammersmith Medicines Research Ltd (London, UK) under MHRA regulatory authorisation and were coordinated by Xceleron Ltd (York, UK), the exploratory clinical development specialist and world leader in the field of Human Microdosing.

Dr Sergio Lociuro, Head of Research of Arpida Ltd. commented "I am very pleased with the results of this first human trial with AR-709. They clearly show that the compound distributes well throughout the body and more importantly in the lungs. In a substantial number of cases, community-acquired respiratory tract infections, caused by S. pneumoniae, require hospitalisation and intravenous therapy. AR-709 appears to have the necessary characteristics to eradicate the microorganisms that can result in serious infections. For cases not requiring hospitalisation and/or to accelerate patient discharge from the hospital, targeted delivery, e.g. via inhalation, could provide a valid and promising alternative to administration via the oral route. Altho
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Arpida adds novel antibiotic AR-2474 to its preclinical pipeline
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Arpida Announces Promising Results First Man Studies With
(Date:10/25/2014)... Research ... addition of the  "Global and Chinese Acne ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... Industry Report 2014 is a professional and ... the global acne medication industry with a ...
(Date:10/25/2014)... , Oct. 24, 2014  As the building ... a company access to diverse skill sets and ... round-the clock business hours for efficiency. However, effectively ... According to recent research, more ... as seeing a project not move forward due ...
(Date:10/22/2014)... 2014  Rescheduling of hydrocodone combination products (HCPs) ... market, according to a new primary market research ... market research and consultation exclusively in the area ... http://photos.prnewswire.com/prnh/20141021/153440 In August, the ... products from Schedule III to Schedule II status. ...
Breaking Medicine Technology:Global and Chinese Acne Medication Industry Report 2014 2Global and Chinese Acne Medication Industry Report 2014 3Work Around the Clock: Successfully Building & Managing Global Virtual Teams 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3
... If you,re thinking about cosmetic surgery, your first stop ... into the future.   SculptMyDream.com is the first website ... using actual 3D photography.  Not only will this help you ... who can turn that dream into reality. (Photo: ...
... Solutions is showcasing its RFSuite RFID tracking and verification ... an RFSuite Symposium Monday, August 1st, from 12:30 – ... Waterfront, Vancouver. The event will include lunch, pre-registration is ... to view the invitation and register . CIVCO,s RFSuite ...
Cached Medicine Technology:See the Results of Your Breast Augmentation, Before Surgery 2CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 2CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817 3
(Date:10/25/2014)... 25, 2014 The global HCIT outsourcing ... 7.6%, to reach $50.4 billion by 2018 from $35 ... industry, and pharmaceutical industry are driving the HCIT outsourcing ... enhance their focus on core business, reduce operational and ... staff (further reducing hiring and training costs), share risk, ...
(Date:10/25/2014)... 2014 Background: , In 1998 Bob ... is a pioneer in the field of establishing recovery community ... treatment system and when he retired, he set out to ... public service. , 1. Where are the ... them? , 2. Can the recovery community be organized ...
(Date:10/25/2014)... TX (PRWEB) October 25, 2014 ... Chinese Molecular Diagnostics Industry, 2009-2019 is a ... and Chinese Molecular Diagnostics industry. The report ... Diagnostics including its classification, application and manufacturing ... China’s top manufacturers of Molecular Diagnostics listing ...
(Date:10/25/2014)... York, New York (PRWEB) October 25, 2014 ... transvaginal mesh lawsuits ( http://www.vaginalmeshlawsuit2015.com/ ) filed ... litigation underway in U.S. District Court, Southern District ... for Summary Judgment on Punitive Damages in a ... plaintiffs. In a ruling issued on October 21st, ...
(Date:10/25/2014)... blood supply to an arm or a leg before heart ... according to a new study. "During heart surgery ... to be able to operate on it. After some time ... produce energy because it doesn,t get oxygen. When we shut ... an arm or a leg, the body prepares for an ...
Breaking Medicine News(10 mins):Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2
... 13 The National Council on,Disability (NCD) will release ... Care System: Barriers to Success and Proposed,Policy Solutions, at ... at,the U.S. Department of Health and Human Services, 200 ... open to the public and the,media and free of ...
... CINCINNATI, Feb. 13, 2008 The Procter & Gamble Company,(NYSE: PG ... J. Johnson, 61, chief legal officer, will retire on June 1, 2008 ... Steven W. Jemison, 56, currently deputy general counsel, will succeed ... John P. Goodwin, 44, currently vice president - finance and ...
... been chosen as a NEO Success Award Winner for ... row that Antares has won this,prestigious award., Since ... top,public, private and emerging companies by revenue and employment. ... of business to,Northeast Ohio,s economic vitality., "Winning the ...
... R.I. - Screening all emergency room patients for carbon ... that can be done even in a high-volume urban ... Rhode Island Hospital. , In the largest study of ... emergency department were routinely screened for exposure to carbon ...
... system for tracking the movement of,the prostate during ... Seattle,Cancer Care Alliance. Featuring tiny GPS-type positioning transponders,implanted ... of the,prostate in real time and alerts technicians ... can adjust the external beam of,radiation., The ...
... editors of the Proceedings of the National Academy of ... the 2007 Cozzarelli Prize, an award for papers that ... , The award was established in 2005 as the ... Cozzarelli Prize in 2007 to honor late PNAS Editor-in-Chief ...
Cached Medicine News:Health News:National Council on Disability to Make Recommendations on Youth with Disabilities in the Foster Care System 2Health News:Procter & Gamble Announces Organizational Changes 2Health News:Antares Management Solutions 2008 NEO Success Award Winner 2Health News:Routine screenings uncover hidden carbon monoxide poisoning 2Health News:Routine screenings uncover hidden carbon monoxide poisoning 3Health News:GPS for the Prostate: System Keeps Radiation Therapy on Target 2Health News:PNAS announces 2007 Cozzarelli Prize recipients 2
The Alexander McQueen eyewear collection focuses on a distinctive sophisticated style, with feminine lines, assertive shapes and original silhouettes....
QC HGB is an assayed quality control material for Hemocue analyzers. This control is a solution of stabilized human red cells and is available in 3 levels for monitoring analyzer performance at sever...
... EP is the first and only contact ... just beginning to have difficulty reading small ... everyone wants to enjoy the best vision ... or reading glasses. Fortunately, Biomedics EPs unique ...
... The table-mounted knee ... exposure for total knee ... flexible, open-frame design allows ... the knee during the ...
Medicine Products: